ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dihydroartemisinin eliminates senescent cells by promoting autophagy-dependent ferroptosis via AMPK/mTOR signaling pathway

Wan, Xing; Li, Can; Tan, Yue Hao; Zuo, Shi Qi; Deng, Feng Mei; Sun, Jing*; Liu, Yi Lun*南方医科大学; 四川大学; 1
CELL BIOLOGY INTERNATIONAL2024-3-4DOI: 10.1002/cbin.12143
3阅读
引用收藏
分享

摘要

Cellular senescence is an irreversible cell-cycle arrest in response to a variety of cellular stresses, which contribute to the pathogenesis of a variety of age-related degenerative diseases. However, effective antisenescence strategies are still lacking. Drugs that selectively target senescent cells represent an intriguing therapeutic strategy to delay aging and age-related diseases. Thus, we thought to investigate the effects of dihydroartemisinin (DHA) on senescent cells and elucidated its mechanisms underlying aging. Stress-induced premature senescence (SIPS) model was built in NIH3T3 cells using H2O2 and evaluated by beta-galactosidase staining. Cells were exposed to DHA and subjected to cellular activity assays including viability, ferroptosis, and autophagy. The number of microtubule-associated protein light-chain 3 puncta was detected by immunofluorescence staining. The iron content was assessed by spectrophotometer and intracellular reactive oxygen species (ROS) was measured by fluorescent probe dichlorodihydrofluorescein diacetate. We found that DHA triggered senescent cell death via ferroptosis. DHA accelerated ferritin degradation via promoting autophagy, increasing the iron contents, promoting ROS accumulation, thus leading to ferroptotic cell death in SIPS cells. In addition, autophagy inhibitor BafA1 preconditioning inhibited ferroptosis induced by DHA. Moreover, Atg5 silencing and autophagy inhibitor BafA1 preconditioning inhibited ferroptosis induced by DHA. We also revealed that the expression of p-AMP-activated protein kinase (AMPK) and p-mammalian target of rapamycin (mTOR) in senescent cells was downregulated. These results suggested that DHA may be a promising drug candidate for clearing senescent cells by inducing autophagy-dependent ferroptosis via AMPK/mTOR signaling pathway.

学科与关键词

关键词
AMPK/mTOR signaling pathwaysautophagydihydroartemisininferroptosissenescence
相关
加载中…
  • Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
    Shi, Hanqiang; Xiong, Lie; Yan, Guang; Du, Shuqin; Liu, Jie; Shi, Yanbo*Frontiers in Molecular Biosciences, 2023, 10: 1156062.被引 8
  • Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells
    Wang, Yajie; Li, Zhijia; Teng, Muzhou*; Liu, Junlin*International Journal of Medical Sciences, 2021, 18(12): 2705-2715.被引 9
  • Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment
    Wang, Youke; Yuan, Xiang; Ren, Min*; Wang, Zhiyu*AMERICAN JOURNAL OF CHINESE MEDICINE, 2024.
查看全部 →

发表信息

论文状态
公开发表
期刊
CELL BIOLOGY INTERNATIONAL
发表日期
2024-03-04
DOI
10.1002/cbin.12143
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2018YFC2002000]; National Key R&D Program of China [S201913705073, S202013705057]; Exploration and Development of Creativity Experiment Project for University Students [19Z13]; Project of Collaborative Innovation Center of Sichuan for Elderly Care and Health

作者

  • W

    Wan, Xing (第一作者)

  • L

    Li, Can

    sichuan univ

查看全部 7 位作者收起作者
  • T

    Tan, Yue Hao

  • Z

    Zuo, Shi Qi

    southern med univ

  • D

    Deng, Feng Mei

    chengdu med coll

  • S

    Sun, Jing (通讯)

    chengdu med coll

  • L

    Liu, Yi Lun (通讯)

    1 · chengdu med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417